Casey Cunningham - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Casey Cunningham’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Advertising,
- Health Care,
- Telecommunications,
- Hospitals,
- E-commerce,
- Payments,
- Wellness,
- Women Founded,
- Enterprise Software,
- Customer Engagement,
- Inventory Management,
- Loyalty Programs,
- Outpatient Care,
- Transportation,
- Search Engine Optimization (SEO),
- Gift Card,
- Retail,
- Information Services,
- Information Technology (IT),
- Email Marketing,
- Technology,
- Finance,
- Software,
- Biotechnology,
- Hispanic / Latinx Founded,
- IT Hardware,
- Landscaping,
- Clinical Trials,
- Consumer Internet,
- Product Search,
- Consumer Software,
- B2C,
- Marketing,
- Logistics,
- Health Diagnostics,
- Medical,
- SaaS,
- Information Technology,
- B2B,
- Therapeutics,
- Online Marketplace,
- Cosmetic Surgery,
- Point of Sale (POS),
- Pharmaceuticals
Social media:
Past investments:
- HNI Healthcare
- Ketra
- Healthcare Highways
- Nirogy Therapeutics
- Claret Medical
- Iterion Therapeutics
- Zeno Corporation
- Terapio
- RiseHealth
- Rex Bionics
- Renascent Medical
- Lumos Pharma
- Explorys
- Protein Discovery
- Guided Interventions
- Farapulse
- LumaTherm
- Geneos Therapeutics
- TVA Medical
- Mary Crowley Cancer Research Centers
- kēlaHealth
- Spinal Restoration
- DyaMX
- BioStable
- Cryosa
- Lyric Pharmaceuticals
- BAROnova
- Millipede
- Molecular Templates
- Mirna Therapeutics
- AbVitro
- Remedy
- Libra Therapeutics
- EndoStim
- Glyscend
- Laguna Pharmaceuticals
Investor Profile
Casey Cunningham is a Venture Capital based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as HNI Healthcare, Ketra, Healthcare Highways, Nirogy Therapeutics, Claret Medical, Iterion Therapeutics, Zeno Corporation, Terapio, RiseHealth, Rex Bionics, Renascent Medical, Lumos Pharma, Explorys, Protein Discovery, Guided Interventions, Farapulse, LumaTherm, Geneos Therapeutics, TVA Medical, Mary Crowley Cancer Research Centers, kēlaHealth, Spinal Restoration, DyaMX, BioStable, Cryosa, Lyric Pharmaceuticals, BAROnova, Millipede, Molecular Templates, Mirna Therapeutics, AbVitro, Remedy, Libra Therapeutics, EndoStim, Glyscend, Laguna Pharmaceuticals. Over time, Casey Cunningham has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Casey Cunningham is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Advertising, Health Care, Telecommunications, Hospitals, E-commerce, Payments, Wellness, Women Founded, Enterprise Software, Customer Engagement, Inventory Management, Loyalty Programs, Outpatient Care, Transportation, Search Engine Optimization (SEO), Gift Card, Retail, Information Services, Information Technology (IT), Email Marketing, Technology, Finance, Software, Biotechnology, Hispanic / Latinx Founded, IT Hardware, Landscaping, Clinical Trials, Consumer Internet, Product Search, Consumer Software, B2C, Marketing, Logistics, Health Diagnostics, Medical, SaaS, Information Technology, B2B, Therapeutics, Online Marketplace, Cosmetic Surgery, Point of Sale (POS), Pharmaceuticals may find it worthwhile to explore potential connections with Casey Cunningham, as their portfolio suggests a familiarity and interest in this area.
Understanding Casey Cunningham’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
